In prostate cancer, studies have confirmed that ETV1 is capable of binding to the matrix metalloproteinase 7 (MMP-7) gene promoter in vitro and ETV1 stimulates the activity of the MMP-7 promoter60. The gene discussed is ETV1; the disease is prostate carcinoma.